Your browser is no longer supported. Please, upgrade your browser.
Settings
NEO NeoGenomics, Inc. daily Stock Chart
NEO [NASD]
NeoGenomics, Inc.
Index- P/E1068.00 EPS (ttm)0.02 Insider Own2.70% Shs Outstand109.64M Perf Week-13.45%
Market Cap2.34B Forward P/E61.91 EPS next Y0.35 Insider Trans-21.58% Shs Float97.82M Perf Month-13.06%
Income1.90M PEG53.40 EPS next Q0.06 Inst Own84.20% Short Float5.39% Perf Quarter-7.49%
Sales342.90M P/S6.83 EPS this Y137.90% Inst Trans9.23% Short Ratio6.27 Perf Half Y7.39%
Book/sh4.98 P/B4.29 EPS next Y30.68% ROA0.40% Target Price28.00 Perf Year57.75%
Cash/sh1.53 P/C13.99 EPS next 5Y20.00% ROE0.50% 52W Range11.05 - 26.89 Perf YTD69.39%
Dividend- P/FCF177.42 EPS past 5Y11.50% ROI2.00% 52W High-20.57% Beta0.92
Dividend %- Quick Ratio4.50 Sales past 5Y33.00% Gross Margin48.30% 52W Low93.30% ATR1.04
Employees1500 Current Ratio4.70 Sales Q/Q50.20% Oper. Margin3.70% RSI (14)34.30 Volatility6.17% 3.92%
OptionableYes Debt/Eq0.22 EPS Q/Q-70.40% Profit Margin0.60% Rel Volume1.17 Prev Close22.55
ShortableYes LT Debt/Eq0.20 EarningsOct 29 BMO Payout0.00% Avg Volume841.03K Price21.36
Recom1.50 SMA20-12.51% SMA50-11.47% SMA2006.12% Volume980,513 Change-5.28%
May-01-19Reiterated Needham Buy $22 → $24
Mar-29-19Reiterated Needham Buy $19 → $22
Jan-03-19Initiated Needham Buy $14
Oct-24-18Upgrade First Analysis Sec Outperform → Strong Buy $18
Aug-21-18Initiated Leerink Partners Outperform $18
May-02-18Downgrade First Analysis Sec Overweight → Equal-Weight $11
Sep-11-17Downgrade BTIG Research Buy → Neutral
Aug-24-17Initiated Gabelli & Co Buy $9
Dec-15-16Initiated Cantor Fitzgerald Overweight $11
Oct-04-16Initiated First Analysis Sec Overweight $11
Jul-27-16Reiterated The Benchmark Company Buy $10 → $12
Apr-28-16Reiterated The Benchmark Company Buy $8 → $9
Mar-11-16Initiated The Benchmark Company Buy $8
Oct-26-15Resumed ROTH Capital Buy $7.50 → $10
Jul-13-15Reiterated ROTH Capital Buy $7 → $7.50
May-14-14Initiated Dawson James Buy $6
Apr-25-13Downgrade Ladenburg Thalmann Buy → Neutral
Feb-14-13Reiterated Ladenburg Thalmann Buy $3.50 → $3.75
Sep-09-19 07:12AM  NeoGenomics Has Attractive Charts and Should Continue Its Uptrend TheStreet.com -7.62%
Sep-03-19 04:15PM  NeoGenomics to Participate in Two Upcoming September Institutional Investor Conferences ACCESSWIRE
Aug-12-19 08:38AM  We Think NeoGenomics (NASDAQ:NEO) Can Manage Its Debt With Ease Simply Wall St.
08:00AM  Neo Performance Materials, Inc. to Host Earnings Call ACCESSWIRE
Aug-08-19 08:45AM  NeoGenomics Announces Leadership Transition and Reiterates Recently Increased 2019 Financial Guidance ACCESSWIRE
Aug-05-19 04:20PM  Here's Why Genetic Testing Stocks Rose as Much as 25.4% in July Motley Fool -7.12%
Aug-02-19 06:41AM  Edited Transcript of NEO earnings conference call or presentation 30-Jul-19 12:30pm GMT Thomson Reuters StreetEvents
Aug-01-19 05:34PM  IBD Stock Of The Day With 93% Gain This Year Breaks Out Again Investor's Business Daily +6.07%
11:01AM  NEO Breaks Out Investor's Business Daily Video
Jul-31-19 07:00AM  NeoGenomics Announces Grand Opening of New Pharma Services Laboratory in Singapore ACCESSWIRE
Jul-30-19 06:23PM  Neogenomics Inc (NEO) Q2 2019 Earnings Call Transcript Motley Fool
09:35AM  NeoGenomics (NEO) Meets Q2 Earnings Estimates Zacks
07:00AM  NeoGenomics Reports 50% Revenue Growth to Record $102 Million in the Second Quarter ACCESSWIRE
Jul-23-19 10:32AM  NeoGenomics (NEO) Earnings Expected to Grow: Should You Buy? Zacks
Jul-12-19 03:13PM  Here's Why NeoGenomics Stock Rose 74% in the First Half of the Year Motley Fool
Jul-11-19 10:38AM  NeoGenomics, Inc. (NASDAQ:NEO): Financial Strength Analysis Simply Wall St.
Jul-09-19 07:00AM  NeoGenomics to Build State-of-the-Art Oncology Laboratory and Global Headquarters in Fort Myers, Florida ACCESSWIRE
Jul-01-19 04:01PM  NeoGenomics Schedules its Second Quarter Earnings Release for July 30, 2019 ACCESSWIRE
Jun-27-19 04:01PM  NeoGenomics Announces New $250 Million Credit Agreement ACCESSWIRE
Jun-23-19 03:51PM  Did Hedge Funds Drop The Ball On NeoGenomics, Inc. (NEO) ? Insider Monkey
May-30-19 04:05PM  NeoGenomics To Present At 39th Annual William Blair Growth Stock Conference ACCESSWIRE
May-28-19 06:00AM  NeoGenomics and QIAGEN Collaborate to Offer Companion Diagnostic Test for HR+/HER2 - Advanced Breast Cancer Patients to Detect a PIK3CA Mutation ACCESSWIRE
May-23-19 04:30PM  NeoGenomics To Attend The 16th Annual Craig-Hallum Institutional Investor Conference ACCESSWIRE
May-21-19 08:10PM  NeoGenomics Announces Pricing on Public Offering of Common Stock ACCESSWIRE -5.82%
07:36AM  Dow Jones Futures Signal Stock Market Rally As China Trade War Tensions Ease Investor's Business Daily
May-20-19 04:12PM  NeoGenomics Announces Proposed Public Offering of Common Stock ACCESSWIRE
May-07-19 12:16PM  Are NeoGenomics, Inc.'s (NASDAQ:NEO) Interest Costs Too High? Simply Wall St. -5.05%
May-03-19 09:15AM  NeoGenomics (NEO) Hits Fresh High: Is There Still Room to Run? Zacks
May-02-19 02:40PM  Hedge Funds Have Never Been This Bullish On NeoGenomics, Inc. (NEO) Insider Monkey
03:30AM  Edited Transcript of NEO earnings conference call or presentation 30-Apr-19 12:30pm GMT Thomson Reuters StreetEvents
Apr-30-19 02:03PM  Neogenomics Inc (NEO) Q1 2019 Earnings Call Transcript Motley Fool
09:35AM  NeoGenomics (NEO) Tops Q1 Earnings and Revenue Estimates Zacks
08:27AM  NeoGenomics: 1Q Earnings Snapshot Associated Press
07:00AM  NeoGenomics Reports 51% Revenue Growth to Record $96 Million in the First Quarter ACCESSWIRE
Apr-23-19 10:32AM  NeoGenomics (NEO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Apr-03-19 04:35PM  NeoGenomics Schedules its First Quarter Earnings Release for April 30, 2019 ACCESSWIRE
Apr-02-19 05:20PM  NeoGenomics to Present at 18th Annual Needham & Company Health Care Conference ACCESSWIRE
Mar-28-19 07:20AM  Report: Developing Opportunities within Carter's, Ingredion, NeoGenomics, American Financial Group, Inogen, and Forrester Research Future Expectations, Projections Moving into 2019 GlobeNewswire
Mar-11-19 12:59PM  Here's Why Genetic Testing Stocks Rose as Much as 42.9% in February Motley Fool
07:00AM  NeoGenomics Launches Immuno-Oncology Companion Diagnostic Test for Triple Negative Breast Cancer in Conjunction with FDA Approval for TECENTRIQ(R) ACCESSWIRE
Mar-07-19 04:50PM  NeoGenomics To Present At 39th Annual Cowen and Company Health Care Conference ACCESSWIRE
Feb-23-19 07:09PM  Back Above $4k: Bitcoins Price Jumps to a Two-Month High Coindesk
Feb-20-19 09:43AM  Edited Transcript of NEO earnings conference call or presentation 19-Feb-19 1:30pm GMT Thomson Reuters StreetEvents
Feb-19-19 02:22PM  Neogenomics Inc (NEO) Q4 2018 Earnings Conference Call Transcript Motley Fool
07:32AM  NeoGenomics: 4Q Earnings Snapshot Associated Press
07:00AM  NeoGenomics Reports Record Revenue of $76 Million with 17% Organic Revenue Growth in the Fourth Quarter GlobeNewswire
06:30AM  NeoGenomics, Inc. to Host Earnings Call ACCESSWIRE
Feb-13-19 08:55AM  Zacks.com featured highlights include: Ready Capital, Gladstone, NeoGenomics, Digi and Paramount Zacks
Feb-12-19 03:00PM  Is NeoGenomics, Inc. (NASDAQ:NEO) Excessively Paying Its CEO? Simply Wall St.
10:30AM  NeoGenomics (NEO) Reports Next Week: What to Know Ahead of the Release Zacks
08:19AM  5 Breakout Stocks for Stellar Returns Zacks
Feb-08-19 10:33PM  Here's Why Genetic Testing Stocks Rose as Much as 31.8% in January Motley Fool
Jan-29-19 01:10PM  NeoGenomics Is Poised For Further Gains - Go Long on a Shallow Dip TheStreet.com
09:30AM  Is NeoGenomics (NEO) Outperforming Other Medical Stocks This Year? Zacks
Jan-28-19 07:00AM  NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2018 Earnings Release for February 19, 2019 GlobeNewswire
Jan-22-19 07:11PM  3 Top Growth Stocks to Buy Right Now Motley Fool
Jan-18-19 07:40AM  Report: Developing Opportunities within Macerich, Illinois Tool Works, NeoGenomics, Bunge, Dolby Laboratories, and Cracker Barrel Old Country Store Future Expectations, Projections Moving into 2019 GlobeNewswire
Jan-09-19 12:41PM  Here's Why NeoGenomics Rocketed Higher Today Motley Fool +13.84%
Jan-08-19 05:58PM  NeoGenomics Set to Join S&P SmallCap 600 PR Newswire
Dec-25-18 09:30AM  Is NeoGenomics (NEO) Stock Outpacing Its Medical Peers This Year? Zacks
Dec-21-18 05:45PM  NeoGenomics (NEO) Stock Moves -1.04%: What You Should Know Zacks
Dec-19-18 12:45AM  NeoGenomics, Inc. (NEO): Hedge Funds Are Snapping Up Insider Monkey
Dec-17-18 10:10AM  GE Sells Last of Its NeoGenomics Stock for $130 Million Barrons.com -5.21%
Dec-14-18 06:57AM  The Zacks Analyst Blog Highlights: Anthem, Ensign, NeoGenomics, Merit Medical Systems and Medpace Zacks
Dec-13-18 10:32AM  5 Healthcare Bets to Stay in Investors Good Books Next Year Zacks
07:00AM  NeoGenomics Appoints Dr. Lawrence M. Weiss as Chief Scientific Officer GlobeNewswire
Dec-12-18 07:35AM  NeoGenomics Announces Pricing on Secondary Offering of Common Stock by Selling Stockholder GlobeNewswire
Dec-11-18 04:10PM  NeoGenomics Announces Secondary Offering of Common Stock by Selling Stockholder GlobeNewswire
Dec-10-18 09:10AM  NeoGenomics Completes Acquisition of Genoptix, Inc. GlobeNewswire
Dec-06-18 09:30AM  Is NeoGenomics (NEO) Outperforming Other Medical Stocks This Year? Zacks -6.57%
Dec-03-18 09:33AM  QIAGEN (QGEN) Partners NeoGenomics to Widen CDx Tests Reach Zacks
Nov-30-18 05:01PM  QIAGEN and NeoGenomics collaborate to offer cancer patients Day-One access to innovative companion diagnostics for newly approved drugs GlobeNewswire
04:04PM  QIAGEN and NeoGenomics collaborate to offer cancer patients Day-One access to innovative companion diagnostics for newly approved drugs Business Wire
Nov-27-18 10:44AM  Eyenovia Initiates Phase III Study for Mydriasis Candidate Zacks
Nov-12-18 03:00PM  What Kind Of Investor Owns Most Of NeoGenomics Inc (NASDAQ:NEO)? Simply Wall St.
07:35AM  Research Report Identifies Ironwood Pharmaceuticals, The AES, Accuray, Ball, Park Hotels & Resorts, and NeoGenomics with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Nov-05-18 09:09PM  Edited Transcript of NEO earnings conference call or presentation 30-Oct-18 12:30pm GMT Thomson Reuters StreetEvents
Oct-30-18 03:33PM  Dow Jones Leads Fragile Rebound; Will This Sector Head A Recovery? Investor's Business Daily +10.41%
08:35AM  NeoGenomics (NEO) Q3 Earnings and Revenues Top Estimates Zacks
07:31AM  NeoGenomics: 3Q Earnings Snapshot Associated Press
07:00AM  NeoGenomics Reports 17% Revenue Growth to Record $69 Million GlobeNewswire
Oct-23-18 01:01PM  [$$] NeoGenomics to Buy Genoptix Inc. for $138.7 Million The Wall Street Journal
07:00AM  NeoGenomics Signs Definitive Agreement to Acquire Genoptix GlobeNewswire
Oct-18-18 09:10AM  Consolidated Research: 2018 Summary Expectations for MaxLinear, NeoGenomics, Intrepid Potash, Glu Mobile, Ingles Markets, and Ball Fundamental Analysis, Key Performance Indications GlobeNewswire
Oct-01-18 07:00AM  NeoGenomics Schedules its Third Quarter Earnings Release for October 30, 2018 GlobeNewswire
Sep-24-18 07:00AM  NeoGenomics Announces Participation in NCI-MATCH Clinical Trial GlobeNewswire
Sep-12-18 08:14AM  NeoGenomics Awarded Clinical Reference Laboratory Testing Services Agreement with Premier GlobeNewswire
Aug-27-18 08:00AM  Research Report Identifies Ball, Aethlon Medical, NeoGenomics, Del Taco Restaurants, Arconic, and Agilysys with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Aug-09-18 08:40PM  NeoGenomics Announces Pricing on Public Offering of Common Stock GlobeNewswire
Aug-06-18 04:19PM  NeoGenomics Announces Proposed Public Offering of Common Stock GlobeNewswire
Jul-30-18 09:30AM  EBS vs. NEO: Which Stock Should Value Investors Buy Now? Zacks
Jul-27-18 07:45AM  Breakfast Technical Briefing on TrovaGene and Three Other Additional Medical Research Stocks ACCESSWIRE
Jul-24-18 07:03PM  Edited Transcript of NEO earnings conference call or presentation 24-Jul-18 12:30pm GMT Thomson Reuters StreetEvents
07:18AM  NeoGenomics: 2Q Earnings Snapshot Associated Press
07:00AM  NeoGenomics Reports Record Revenue of $67.7 Million with 14% Increase in Clinical Volume Growth and 95% Increase in Pharma Services Backlog GlobeNewswire
06:30AM  NeoGenomics, Inc. to Host Earnings Call ACCESSWIRE
Jul-23-18 04:18PM  Earnings Preview For NeoGenomics Benzinga
Jul-11-18 09:30AM  EBS vs. NEO: Which Stock Is the Better Value Option? Zacks
Jul-02-18 04:05PM  NeoGenomics Schedules its Second Quarter Earnings Release for July 24, 2018 GlobeNewswire +5.03%
Jun-29-18 07:30AM  [$$] GE Is Doing Well---in Its Stock Investments Barrons.com
NeoGenomics, Inc., together with its subsidiaries, operates a network of cancer-focused genetic testing laboratories in the United States; and laboratories in Switzerland and Singapore. It operates in two segments, Clinical Services and Pharma Services. The company's laboratories provide genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, pharmaceutical firms, academic centers, and other clinical laboratories. It offers cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; immunohistochemistry and digital imaging testing services to localize proteins in cells of a tissue section, as well as to allow clients to see and utilize scanned slides, and perform quantitative analysis for various stains; and molecular testing services, which focus on the analysis of DNA and RNA, and the structure and function of genes at the molecular level. The company also provides pathology consultation services for clients in which its pathologists review surgical samples on a consultative basis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization, as well as acts as a reference laboratory supplying anatomic pathology testing services. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
JONES STEVEN CDirectorSep 10Sale21.471,20025,76446,457Sep 10 08:32 PM
HANNAH ALISON L.DirectorSep 09Option Exercise8.4111,66698,11176,098Sep 11 08:00 PM
JONES STEVEN CDirectorSep 09Sale25.003751,676,230Sep 10 08:32 PM
JONES STEVEN CDirectorSep 06Sale25.001,69142,2751,676,233Sep 10 08:32 PM
JONES STEVEN CDirectorAug 30Sale25.001,20030,0001,677,924Aug 30 05:10 PM
Bonello WilliamChief Strategy OfficerAug 28Option Exercise7.5217,000127,84023,735Aug 30 05:15 PM
Bonello WilliamChief Strategy OfficerAug 28Sale24.8317,000422,1106,735Aug 30 05:15 PM
JONES STEVEN CDirectorAug 28Sale25.0239,537989,2161,679,124Aug 30 05:10 PM
JONES STEVEN CDirectorAug 27Sale24.9530,280755,4861,718,661Aug 27 05:40 PM
JONES STEVEN CDirectorAug 26Sale24.87143,6033,571,4071,748,941Aug 27 05:40 PM
Johnson Kevin CDirectorAug 26Sale24.7411,800291,93228,285Aug 27 05:41 PM
HIPP RAYMOND RDirectorAug 26Sale24.7915,424382,361134,102Aug 27 05:44 PM
HIPP RAYMOND RDirectorAug 23Option Exercise9.269,12784,527150,126Aug 27 05:44 PM
Johnson Kevin CDirectorAug 23Sale25.6041,2001,054,72040,085Aug 27 05:41 PM
JONES STEVEN CDirectorAug 23Sale25.727,456191,7681,892,544Aug 27 05:40 PM
HIPP RAYMOND RDirectorAug 23Sale25.0260015,012149,526Aug 27 05:44 PM
HIPP RAYMOND RDirectorMay 08Sale22.36118,4792,649,190137,580May 09 09:55 PM
HIPP RAYMOND RDirectorMay 07Sale22.6131,521712,690256,059May 09 09:55 PM
Bonello WilliamChief Strategy OfficerMay 06Option Exercise7.527,20054,14413,935May 08 05:02 PM
Bonello WilliamChief Strategy OfficerMay 06Sale23.537,200169,4166,735May 08 05:02 PM
BALLIET JENNIFERVP and Chief Culture OfficerMay 03Sale22.7430,000682,20022,862May 06 05:33 PM
CARDOZA GEORGEPresident, Pharma ServicesMay 03Sale22.82151,6763,461,246300,831May 06 05:30 PM
CARDOZA GEORGEPresident, Pharma ServicesMay 02Option Exercise4.78200,000956,000452,507May 06 05:30 PM
SHOVLIN ROBERT J.President, Clinical ServicesMay 02Option Exercise7.34133,333977,998281,654May 06 05:31 PM
BALLIET JENNIFERVP and Chief Culture OfficerMay 02Option Exercise7.3130,000219,43352,862May 06 05:33 PM
SHOVLIN ROBERT J.President, Clinical ServicesMay 02Sale22.14119,3472,642,343162,307May 06 05:31 PM
BALLIET JENNIFERVP and Chief Culture OfficerMar 04Option Exercise8.0314,000112,42036,862Mar 04 05:25 PM
BALLIET JENNIFERVP and Chief Culture OfficerMar 04Sale19.0914,000267,26022,862Mar 04 05:25 PM
SHOVLIN ROBERT J.President, Clinical ServicesFeb 28Option Exercise7.1513,986100,000137,377Feb 28 05:05 PM
BALLIET JENNIFERVP and Chief Culture OfficerFeb 28Option Exercise7.6930,000230,70050,000Mar 04 05:25 PM
BALLIET JENNIFERVP and Chief Culture OfficerFeb 28Sale19.5730,000587,10020,000Mar 04 05:25 PM
CARDOZA GEORGEPresident, Pharma ServicesFeb 27Option Exercise3.4530,000103,500244,089Feb 28 07:42 PM
JONES STEVEN CExecutive Vice PresidentFeb 27Sale18.89285,2525,387,378150,000Feb 28 08:25 PM
SHOVLIN ROBERT J.President, Clinical ServicesFeb 27Sale19.2344,135848,716123,391Feb 28 05:05 PM
HIPP RAYMOND RDirectorFeb 26Option Exercise6.4918,889122,646306,469Feb 28 04:57 PM
Bonello WilliamChief Strategy OfficerFeb 26Option Exercise7.8660,203473,21160,203Feb 28 04:59 PM
SHOVLIN ROBERT J.President, Clinical ServicesFeb 26Option Exercise7.28186,0141,354,667309,405Feb 28 05:05 PM
Bonello WilliamChief Strategy OfficerFeb 26Sale18.9060,2031,137,8370Feb 28 04:59 PM
HIPP RAYMOND RDirectorFeb 26Sale18.9018,889357,002287,580Feb 28 04:57 PM
SHOVLIN ROBERT J.President, Clinical ServicesFeb 26Sale18.88141,8792,678,676167,526Feb 28 05:05 PM
JONES STEVEN CExecutive Vice PresidentFeb 26Sale19.2414,621281,36547,657Feb 28 08:25 PM
Johnson Kevin CDirectorDec 21Buy11.6026,000301,600103,866Dec 26 07:08 PM
GENERAL ELECTRIC COFormer 10% OwnerDec 14Sale12.0010,835,145130,021,7400Dec 14 04:05 PM
TETRAULT LYNN A.DirectorNov 19Sale16.0013,000207,94038,234Nov 21 01:33 PM
TETRAULT LYNN A.DirectorNov 15Option Exercise7.4918,888141,43756,234Nov 16 05:18 PM
TETRAULT LYNN A.DirectorNov 14Sale16.165,00080,80051,234Nov 16 05:18 PM
JONES STEVEN CExecutive Vice PresidentNov 14Sale16.505,55391,625184,271Nov 14 07:30 PM
JONES STEVEN CExecutive Vice PresidentNov 13Sale16.6935,574593,610186,000Nov 14 07:30 PM
SHOVLIN ROBERT J.President, Clinical ServicesNov 12Sale16.7636,493611,623123,391Nov 13 10:27 AM
JONES STEVEN CExecutive Vice PresidentNov 12Sale16.66100,0001,666,0002,200,000Nov 14 07:30 PM
BALLIET JENNIFERVP and Chief Culture OfficerNov 12Sale16.7328,505476,88920,000Nov 13 08:46 PM
BALLIET JENNIFERVP and Chief Culture OfficerNov 09Option Exercise2.4568,333167,30088,333Nov 13 08:46 PM
SHOVLIN ROBERT J.President, Clinical ServicesNov 09Option Exercise4.79300,0001,437,000339,884Nov 13 10:27 AM
Johnson Kevin CDirectorNov 09Sale17.0366,0071,124,18077,866Nov 13 10:48 AM
SHOVLIN ROBERT J.President, Clinical ServicesNov 09Sale17.05180,0003,069,000159,884Nov 13 10:27 AM
GENERAL ELECTRIC CO10% OwnerNov 09Sale16.754,164,85569,761,32110,835,145Nov 13 05:05 PM
BALLIET JENNIFERVP and Chief Culture OfficerNov 09Sale17.0039,828677,07648,505Nov 13 08:46 PM
BRODIE STEVEN G.VP - Pharma OperationsOct 22Option Exercise3.4513,33446,00245,953Oct 24 06:36 PM